Study Reference No. - C2A05608
| Study Reference No. | Study Type | Compensation | Gender | Age | Demographic |
|---|---|---|---|---|---|
| C2A05608 | Birch Allergy | Up to $11,300 | Males & Females | 18 - 65 years | In general good healthy; history of birch pollen allergy for at least the past 2 years; non-smokers OR smokers (<20 cigarettes per day) |
Study Details |
|
Study Purpose |
The primary purpose of this study is to find out how treatment with DM-101PX (test drug) affects nasal symptoms compared to placebo after exposure to birch pollen during a nasal allergen challenge (NAC). NAC is a procedure which involves applying a small amount of allergen (such as birch pollen) to the inside of your nose to trigger a mild and temporary allergic reaction, similar to what you might experience during the allergy season. |
Study Duration |
Study duration is approximately a minimum of 201 days and a maximum of 351 days with 15 clinic visits including screening. |
Study Schedule |
|
General Screening |
NA |
Medical Screening |
Contact recruitment. Multiple dates available. |
Study Visit(s) |
Contact Recruitment. |
Follow-Up Visit(s) |
Contact recruitment. |
Other Notes |
|
Bring Valid Photo ID. Refer a friend and you may be eligible to receive up to $100 per referral. |
|